Respiratory syncytial virus (RSV) is one of the most common viral respiratory infections globally, with a rising incidence among children under five years of age. This study aimed to describe RSV and subsequent wheezing burden in toddlers infected between the ages of 6 and 24 months and their parents.

Patients with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2– negative (HER2−) early breast cancer (EBC) remain at risk of early (≤5 years) and late (>5 years) disease recurrences despite standard-of-care adjuvant endocrine therapy.

Up to 27% of all patients with BC will recur within 10 years of diagnosis, particularly if initially diagnosed at stage II or III where recurrence rates are 41% and 63%, respectively. Currently, there is little published evidence related to the concerns of patients and caregivers concerning risk of recurrence (ROR). Lack of awareness about ROR has considerable impact on patient and caregiver quality of life, which may result in emotional distress from being unprepared about the true ROR.
Here, we present important insights on ROR through the combined results of an online patient survey and subsequent social media analysis (SMA) of patients and caregivers.

Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in children. This study aimed to describe RSV and subsequent wheezing burden in toddlers aged 6 to 24 months and their parents.

Multiple myeloma (MM) is a malignant plasma cell disorder characterized by the clonal expansion of abnormal plasma cells within the bone marrow. The management of relapsed/refractory multiple myeloma (RRMM) represents a significant challenge as the disease relapses or becomes
refractory to previous treatments. Recent advances in therapy have expanded RRMM treatment options. This study aimed to gain a deeper understanding of patients’ treatment preferences regarding available therapeutic options.

Immune thrombocytopenia (ITP) is a chronic disease with primary therapeutic goals of platelet
count recovery to safe levels to minimize active/future bleeding, alongside easing additional
symptoms negatively impacting overall patient well-being with consequent improvement in
physical fatigue/energy levels, daily/work-related activities and social/emotional health.
Documentation of this rare disease is important for evaluating real-world experiences in treatment
satisfaction, expectations and unmet needs in disease management.
This study examined patient experiences and preferences, treatment satisfaction and expectations
and unmet patient needs related to disease management and control based on the outcomes of a
survey conducted in adults with ITP.

This study examines the use, perceptions, and inequalities in access to Digital Health Solutions (DHS) among people with diabetes (PwD). It aims to identify factors influencing adoption and explore perceived benefits and barriers to using DHS, focusing on person-important outcomes such as physical health, mental burden, and access to care.

Approximately 15 million infants are born prematurely each year. Preterm status is often associated with lifelong chronic respiratory conditions, such as asthma and Chronic Obstructive Pulmonary Disease (COPD) [2]. Data on prematurity impact on respiratory disease progression and management in adulthood remain limited. This study aims to investigate patient awareness of their preterm status, its perceived impact on their respiratory health, and how healthcare professionals
(HCPs) consider preterm status when managing these conditions.

CDD is a developmental epileptic encephalopathy condition causing severe developmental delay, epileptic seizures, important psychomotor impairment with limited communication skills from the first months of life. The objective was to better understand the burden of CDD on both patients and their family from the perspective of caregivers.

This study was designed to do something rare: let caregivers tell us the true story, not just through words, but through data that regulators, pharma, and policy makers will listen to

Understanding patient preferences is important for facilitating informed decision-making in managing patients with inflammatory bowel disease (IBD). This study explored the preferences of patients with Crohn’s disease (CD) and ulcerative colitis (UC) regarding advanced therapy treatment attributes in five non-Western countries: Argentina, Australia, Brazil, Saudi Arabia and Taiwan.